Arrowstreet Capital
EDIT icon

Arrowstreet Capital’s Editas Medicine EDIT Stock Holding History

Arrowstreet Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-7,252
Closed -$260K – 1128
2018
Q2 		$260K Sell
7,252
-340,509
-98% -$12.1M ﹤0.01% 989
2018
Q1 		$11.5M Buy
347,761
+173,626
+100% +$6.19M 0.03% 417
2017
Q4 		$5.35M Buy
174,135
+156,535
+889% +$3.94M 0.01% 594
2017
Q3 		$423K Buy
17,600
+600
+4% +$11.4K ﹤0.01% 959
2017
Q2 		$285K Buy
+17,000
New +$306K ﹤0.01% 955
2016
Q4 		– Sell
-86,598
Closed -$1.17M – 1864
2016
Q3 		$1.17M Buy
+86,598
New +$1.77M ﹤0.01% 1039

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Arrowstreet Capital's EDIT Position: Q3 2018 in Review

Arrowstreet Capital sold out of Editas Medicine (EDIT) in Q3 2018, closing a stake of 7,252 shares — an estimated $260K sold.

Arrowstreet Capital first reported a position in EDIT in Q3 2016 and held it in 6 quarters. The position peaked at $11.5M in Q1 2018. 199 funds tracked by Wall St. Rank hold EDIT as of Q3 2018.

  • Arrowstreet Capital reported no remaining Editas Medicine position as of Q3 2018 after selling out during the quarter.
  • Arrowstreet Capital sold 7,252 Editas Medicine shares in Q3 2018, an estimated $260K.
  • Arrowstreet Capital first reported a position in Editas Medicine in Q3 2016 and held it in 6 quarters.
  • Arrowstreet Capital's Editas Medicine position peaked at $11.5M in Q1 2018.
  • 199 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2018.

Based on Arrowstreet Capital's 13F filing for Q3 2018, filed 14 Nov 2018.